Proteome Sciences PLC (PRM)

ORD 1P

Sell: 2.04p|Buy: 2.58p|Change: 0.05 (-2.12%)

Open

2.1102p

Previous close

2.36p

Trade high

2.1102p

Volume

7,276

Year high

5.40p

Year low

1.30p

Dividend yield

–

Market capitalisation

£6.82 mn

P/E ratio

17.43

ISIN

GB0003104196

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 12/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Proteome Sciences PLC	- 2.12
FTSE AIM All Share	+ 0.18
More...

Company profile

Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
12/12/2025	03:52:04	2.1102	6,042	127.50
12/12/2025	03:32:41	2.04	744	15.18
12/12/2025	03:32:41	2.04	490	10.00
11/12/2025	08:00:17	2.02	231	4.67
11/12/2025	08:00:17	2.7	38	1.03

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.